UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mesonephric‐like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas

Histopathology, 2023-06, Vol.82 (7), p.978-990

2023

Volltextzugriff (PDF)

Histological grading of ovarian mucinous carcinoma – an outcome‐based analysis of traditional and novel systems

Histopathology, 2020-07, Vol.77 (1), p.26-34

2020

Volltextzugriff (PDF)

Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers

Cancer medicine (Malden, MA), 2012-10, Vol.1 (2), p.237-260

2012

Volltextzugriff (PDF)

Molecular correlates of invasion pattern in HPV‐associated endocervical adenocarcinoma: emergence of two distinct risk‐stratified tiers

Histopathology, 2023-06, Vol.82 (7), p.1067-1078

2023

Volltextzugriff (PDF)

Genomic profiling of dedifferentiated endometrial carcinomas arising in the background of high‐grade carcinoma: a targeted next‐generation sequencing study

Histopathology, 2023-09, Vol.83 (3), p.366-375

2023

Volltextzugriff (PDF)

Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma

Scientific reports, 2022-01, Vol.12 (1), p.716-716, Article 716

2022

Volltextzugriff (PDF)

Cytohistologic immunohistochemical correlation of epithelial tubo‐ovarian neoplasms: Can cell blocks substitute for tissue?

Cancer cytopathology, 2023-02, Vol.131 (2), p.100-109

2023

Volltextzugriff (PDF)

MTAP protein status is highly concordant with CDKN2A fluorescent in situ hybridization and allows stratification of the luminal subtype in muscle-invasive bladder cancer

Histopathology, 2024-09

2024

Volltextzugriff (PDF)

MLH1 Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal

Cancers, 2023-11, Vol.15 (21), p.5188

2023

Volltextzugriff (PDF)

Implementation of HER2 Testing in Endometrial Cancer, a Summary of Real-World Initial Experience in a Large Tertiary Cancer Center

Cancers, 2024-05, Vol.16 (11), p.2100

2024

Volltextzugriff (PDF)

Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification

Cancers, 2022-10, Vol.14 (19), p.4911

2022

Volltextzugriff (PDF)

Utility of intraoperative pathology consultations of whipple resection specimens and their impact on final margin status

Heliyon, 2023-09, Vol.9 (9), p.e20238, Article e20238

2023

Volltextzugriff (PDF)

A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer

Clinical epigenetics, 2018-11, Vol.10 (1), p.147-147, Article 147

2018

Volltextzugriff (PDF)

Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer

Translational oncology, 2017-04, Vol.10 (2), p.168-177

2017

Volltextzugriff (PDF)

Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer

Epigenetics, 2012-09, Vol.7 (9), p.1037-1045

2012

Volltextzugriff (PDF)

Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer

Oncotarget, 2014-09, Vol.5 (17), p.7858-7869

2014

Volltextzugriff (PDF)

International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome

Journal of clinical pathology, 2019-05, Vol.72 (5), p.347-353

2019

Volltextzugriff (PDF)

5/#274 Is reflex MLH1 promoter hypermethylation testing following MLH1 loss by immunohistochemistry in endometrial carcinoma best practice?

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A26-A27

2022

Volltextzugriff (PDF)

p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis

The American journal of surgical pathology, 2019-12, Vol.43 (12), p.1591-1599

2019

Volltextzugriff (PDF)

IMLH1/I Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal

Cancers, 2023-10, Vol.15 (21)

2023

Volltextzugriff (PDF)

The Impact of the Pathologist in Multidisciplinary Cancer Conferences on Patient Care : Evidence From the Literature

American journal of clinical pathology, 2023-04, Vol.159 (4), p.352-357

2023

Volltextzugriff (PDF)

EP206/#943 The spectrum of HER2 expression in endometrial carcinoma

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A161-A161

2023

Volltextzugriff (PDF)

EP204/#941 Correlation between HER2 testing by immunohistochemistry-ish and ERBB2 determined by next generation sequencing

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A159-A160

2023

Volltextzugriff (PDF)

CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome

The American journal of surgical pathology, 2021-01, Vol.45 (1), p.68-76

2021

Volltextzugriff (PDF)

Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression

Journal of clinical pathology, 2022-11, Vol.75 (11), p.766-771

2022

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(60)
Dissertationen
(1)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mesonephric‐like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas

Histological grading of ovarian mucinous carcinoma – an outcome‐based analysis of traditional and novel systems

Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers

Molecular correlates of invasion pattern in HPV‐associated endocervical adenocarcinoma: emergence of two distinct risk‐stratified tiers

Genomic profiling of dedifferentiated endometrial carcinomas arising in the background of high‐grade carcinoma: a targeted next‐generation sequencing study

Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma

Cytohistologic immunohistochemical correlation of epithelial tubo‐ovarian neoplasms: Can cell blocks substitute for tissue?

MTAP protein status is highly concordant with CDKN2A fluorescent in situ hybridization and allows stratification of the luminal subtype in muscle-invasive bladder cancer

MLH1 Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal

Implementation of HER2 Testing in Endometrial Cancer, a Summary of Real-World Initial Experience in a Large Tertiary Cancer Center

Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification

Utility of intraoperative pathology consultations of whipple resection specimens and their impact on final margin status

A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer

Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer

Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer

Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer

International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome

5/#274 Is reflex MLH1 promoter hypermethylation testing following MLH1 loss by immunohistochemistry in endometrial carcinoma best practice?

p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis

IMLH1/I Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal

The Impact of the Pathologist in Multidisciplinary Cancer Conferences on Patient Care : Evidence From the Literature

EP206/#943 The spectrum of HER2 expression in endometrial carcinoma

EP204/#941 Correlation between HER2 testing by immunohistochemistry-ish and ERBB2 determined by next generation sequencing

CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome

Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression

Suchergebnisse filtern